Full Press Release Details
arGEN-X concludes EUR 12.5 million Series A financing round.
ARGX
arGEN-X concludes EUR 12.5 million Series A financing round
Key Takeaway: arGEN-X concludes EUR 12.5 million Series A financing round
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis